PriceSensitive

Harvest One (TSXV: HVT) expands its LivRelief product portfolio with the launch of new CBD cream

Cannabis
TSXV:HVT
13 May 2021 15:15 (EDT)

Harvest One Cannabis Inc. (HVT) has expanded its LivRelief product line with the launch of the new Extra Strength Transdermal CBD Cream.

The cream contains 750 milligrams of CBD and offers consumers three times the amount of cannabinoids found in the original LivRelief cream.

With this new addition, Harvest One’s portfolio of infused topical products provides customers with more choice to suit their individual needs.

Gord Davey, president and CEO of Harvest One, commented,

“Harvest One’s LivRelief CBD Cream continues its momentum of being the top-selling SKU in the Infused Topicals category in Ontario for the twelve-month period ended March 2021, as ranked by dollars sold, based on OCS Sales Data.”

He added that the new extra strength product “will launch on the Medical Cannabis by Shoppers platform in June 2021.”

Launching this new product is part of Harvest One’s 2021 strategic growth and brand expansion initiative, with plans to expand offerings in Canada and in legal global markets.

The company remains committed to robust product research and development to ensure it continually meets the needs of the growing cannabis consumer base.

Harvest One is a global leader of cannabis infused products that develops and distributes premium health, wellness and selfcare products with a market focus on sleep and pain.

The company is uniquely positioned in the cannabis space with a focus on both cannabis-infused and non-infused consumer packaged goods.

Harvest One Cannabis Inc. (HVT) is down 5.56 per cent and is trading at $0.085 per share as of 2:55 pm ET.

Related News